IgE-mediated latex allergy - An exciting and instructive piece of allergy history

Pediatric Allergy and Immunology

Volumn 21, Issue 7, 2010, Pages 997-1001

  Niggemann, Bodo ^a  

^a German Red Cross Hospital   (Germany)

Author keywords

Allergy; Avoidance; Health care workers; Latex; Prevention; Sensitization spreading; Spina bifida

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; LATEX;

ALLERGY; ARTICLE; CENTRAL NERVOUS SYSTEM; CHILD; HIGH RISK POPULATION; HUMAN; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK FACTOR; SENSITIZATION; SPINA BIFIDA;

ANIMALS; CENTRAL NERVOUS SYSTEM; CHILD; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNIZATION; LATEX HYPERSENSITIVITY; OCCUPATIONAL EXPOSURE; PREVALENCE; RISK; RUBBER; SPINAL DYSRAPHISM;

EID: 77958579859     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2010.01006.x     Document Type: Article

References (61)

1. Schwartz HJ. Latex: a potential hidden "food" allergen in fast food restaurants. J Allergy Clin Immunol 1995: 95: 139-40.
2. Stern G. Überempfindlichkeit gegen Kautschuk als Ursache von Urticaria und Quinckeschem Ödem. Klin Woschr 1927: 6: 1096-7.
3. Nutter A. Contact urticaria to rubber. Br J Dermatol 1979: 101: 597-8.
4. Axelsson IGK, Eriksson M, Wrangsjö K. Anaphylaxis and angioedema due to rubber allergy in children. Acta Paediatr Scand 1988: 77: 314-6.
5. Niggemann B, Breiteneder H. Latex allergy in children. Int Arch Allergy Immunol 2000: 121: 98-107.
6. Michael T, Niggemann B, Moers A, Seidel U, Scheffner D, Wahn U. Risk factors for latex allergy in patients with spina bifida. Clin Exp Allergy 1996: 26: 934-9.
7. Fisher AA. Contact urticaria and anaphylactoid reaction due to corn starch surgical glove powder. Contact Dermatitis 1987: 16: 224-35.
8. Assalve D, Cicioni C, Perno P, Lisi P. Contact urticaria and anaphylactoid reaction from cornstarch surgical glove powder. Contact Dermatitis 1988: 19: 61-78.
9. Seggev JS, Mawhinney TP, Yunginger JW, Braun SR. Anaphylaxis due to cornstarch surgical glove powder. Ann Allergy 1990: 65: 152-5.
10. Tomazic VJ, Shampaine EL, Lamanna A, Withow TJ, Adkinson NF Jr, Hamilton RG. Cornstarch powder on latex products is an allergen carrier. J Allergy Clin Immunol 1994: 93: 751-8.
11. Heilman DK. A prospective, controlled study showing that rubber gloves are the major contributor to latex aeroallergen levels in the operating room. J Allergy Clin Immunol 1994: 98: 325-30.
12. Barbara J, Santais MC, Levy DA, Ruff F, Leynadier F. Immunoadjuvant properties of glove cornstarch powder in latex-induced hypersensitivity. Clin Exp Allergy 2003: 33: 106-12.
13. Gold M, Swartz JS, Braude BM, Dolovich J, Shandling B, Gilmour RF. Intraoperative anaphylaxis: an association with latex sensitivity. J Allergy Clin Immunol 1991: 87: 662-6.
14. Kelly KJ, Pearson ML, Kurup VP, et al. A cluster of anaphylactic reactions in children with spina bifida during general anesthesia: epidemiologic features, risk factors, and latex hypersensitivity. J Allergy Clin Immunol 1994: 94: 53-61.
15. Liebke C, Niggemann B, Wahn U. Sensitivity and allergy to latex in atopic and non-atopic children. Pediatr Allergy Immunol 1996: 7: 103-7.
16. Bernadini R, Novembre E, Lombardi E, et al. Risk factors for latex allergy in patients with spina bifida and latex sensitization. Clin Exp Allergy 1999: 29: 681-6.
17. Moneret Vautrin DA, Beaudouin E, Widmer S, et al. Prospective study of risk factors in natural rubber latex hypersensitivity. J Allergy Clin Immunol 1993: 92: 668-77.
18. Ownby DR, Ownby HE, McCullough J, Shafer AW. The prevalence of anti-latex antibodies in 1000 volunteer blood donors. J Allergy Clin Immunol 1996: 97: 1188-92.
19. Grzybowski M, Ownby DR, Peyser PA, Johnson CC, Schork MA. The prevalence of anti-latex antibodies among registered nurses. J Allergy Clin Immunol 1996: 98: 535-44.
20. Lagier F, Vervloet D, Lhermet I, Poyen D, Charpin D. Prevalence of latex allergy in operating room nurses. J Allergy Clin Immunol 1992: 90: 319-22.
21. Liss GM, Sussman GL, Deal K, et al. Latex allergy: epidemiological study of 1351 hospital workers. Occup Environ Med 1997: 54: 335-42.
22. Yassin MS, Lierl MB, Fischer TJ, O'Brien K, Steinmetz C. Latex allergy in hospital employees. Ann Allergy 1994: 72: 245-9.
23. Turjanmaa K, Alenius H, Mäkinen Kiljunen S, Reunala T, Palosuo T. Natural rubber latex allergy. Allergy 1996: 51: 593-602.
24. Berky ZT, Luciano WJ, James WD. Latex glove allergy. A survey of the US Army Dental Corps. JAMA 1992: 268: 2695-7.
25. Tarlo SM, Sussman GL, Holness DL. Latex sensitivity in dental students and staff: a cross-sectional study. J Allergy Clin Immunol 1997: 99: 396-401.
26. Johar A, Lim DL, Mad Arif SA, et al. Low prevalence of latex sensitivity in South African spina bifida children in Cape Town. Pediatr Allergy Immunol 2005: 16: 165-70.
27. Bernadini R, Novembre E, Ingargiola A, et al. Prevalence and risk factors of latex sensitization in an unselected pediatric population. J Allergy Clin Immunol 1998: 101: 621-5.
28. Slater JE, Mostello LA, Shaer C. Rubber-specific IgE in children with spina bifida. J Urol 1991: 146: 578-9.
29. Tosi LL, Slater JE, Shaer C, Mostello LA. Latex allergy in spina bifida patients: prevalence and surgical implications. J Pediatr Orthop 1993: 13: 709-12.
30. Beaudouin E, Prestat F, Schmitt M, Kanny G, Laxenaire MC, Moneret Vautrin DA. High risk of sensitization to latex in children with spina bifida. Eur J Pediatr Surg 1994: 4: 90-3.
31. Kelly KJ, Kurup V, Zacharisen M, Resnick A, Fink JN. Skin and serologic testing in the diagnosis of latex allergy. J Allergy Clin Immunol 1993: 91: 1140-5.
32. Niggemann B, Buck D, Michael T, Wahn U. Latex provocation tests in patients with spina bifida: who is at risk of becoming symptomatic? J Allergy Clin Immunol 1998: 102: 665-70.
33. Yassin MS, Sanyurah S, Lierl MB, et al. Evaluation of latex allergy in patients with meningomyelocele. Ann Allergy 1992: 69: 207-11.
34. Beezhold D, Pugh B, Liss G, Sussman G. Correlation of protein levels with skin prick test reactions in patients allergic to latex. J Allergy Clin Immunol 1996: 98: 1097-102.
35. Scheiner O, Wagner B, Wagner S, et al. Cloning and molecular characterization of Hev b 3, a spina-bifida-associated allergen from hevea brasiliensis latex. Int Arch Allergy Immunol 1999: 118: 311-2.
36. Bohle B, Wagner B, Vollmann U, et al. Characterization of T cell responses to Hev b 3, an allergen associated with latex allergy in spina bifida patients. J Immunol 2000: 164: 4393-8.
37. Yeang HY, Cheong KF, Sunderasan E, et al. The 14.6 kd rubber elongation factor (Hev b 1) and 24 kd (Hev b 3) rubber particle proteins are recognized by IgE from patients with spina bifida and latex allergy. J Allergy Clin Immunol 1996: 98: 628-39.
38. Wagner B, Buck D, Hafner C, et al. Hev b 7 is a Hevea brasiliensis protein associated with latex allergy in children with spina bifida. J Allergy Clin Immunol 2001: 108: 621-7.
39. Raulf Heimsoth M, Chen Z, Liebers V, Allmers H, Baur X. Lymphocyte proliferation response to extracts from different latex materials and to the purified latex allergen Hev b 1 (rubber elongation factor). J Allergy Clin Immunol 1996: 98: 640-5.
40. Barre A, Culerrier R, Granier C, et al. Mapping of IgE-binding epitopes on the major latex allergen Hev b 2 and the cross-reacting 1, 3beta-glucanase fruit allergens as a molecular basis for the latex-fruit syndrome. Mol Immunol 2009: 46: 1595-604.
41. Ganglberger E, Radauer C, Wagner S, et al. Hev b 8, the Hevea brasiliensis latex profilin, is a cross-reactive allergen of latex, plant foods and pollen. Int Arch Allergy Immunol 2001: 125: 216-27.
42. Niggemann B, Bauer A, Jendroska K, Wahn U. Latex allergy as a cause of eosinophilia in cerebrospinal fluid in a child with a ventricular shunt. J Allergy Clin Immunol 1997: 100: 849-50.
43. Tung H, Raffel C, Mccomb JG. Ventricular cerebrospinal fluid eosinophilia in children with ventriculoperitoneal shunts. J Neurosurg 1991: 75: 541-4.
44. Nieto A, Estornell F, Mazón A, Reig C, Nieto A, García Ibarra F. Allergy to latex in spina bifida: a multivariate study of associated factors in 100 consecutive patients. J Allergy Clin Immunol 1996: 98: 501-7.
45. Buck D, Michael T, Wahn U, Niggemann B. Ventricular shunts and the prevalence of sensitization and clinically relevant allergy to latex in patients with spina bifida. Pediatr Allergy Immunol 2000: 11: 111-5.
46. Degenhardt P, Golla S, Wahn F, Niggemann B. Latex allergy in pediatric surgery is dependent on repeated operations in the first year of life. J Pediatr Surg 2001: 36: 1535-9.
47. Wagner S, Breiteneder H. The latex-fruit syndrome. Biochem Soc Trans 2002: 30: 935-40.
48. Niggemann B, Reibel S, Hipler C, Wahn U. Anaphylactic reaction to lychee in a 12-year old girl: cross-reactivity to latex? Pediatr Allergy Immunol 2002: 13: 64-7.
49. Niggemann B, Kulig M, Bergmann R, Wahn U. Development of latex allergy in children up to 5-years of age - a retrospective analysis of risk factors. Pediatr Allergy Immunol 1998: 9: 36-9.
50. Baur X, Rennert J, Chen Z. Latex allergen elimination in natural latex sap and latex gloves by treatment with alkaline potassium hydroxide solution. Allergy 1997: 52: 306-11.
51. Beezhold D, Hickey VL, Koystal DA, et al. Lipid transfer protein from Hevea brasiliensis (Hev b 12), a cross-reactive latex protein. Ann Allergy Asthma Immunol 2003: 90: 439-45.
52. Levy DA, Allouche S, Chabane MH, Leynadier F. Powder-free protein-poor rubber latex gloves and latex sensitization. JAMA 1999: 281: 988.
53. Tarlo SM, Sussman G, Contala A, Swanson MC. Control of airborne latex by use of powder-free latex gloves. J Allergy Clin Immunol 1994: 93: 985-9.
54. Niggemann B, Buck D, Michael T, Haberl H, Wahn U. Latex allergy in spina bifida - at the turning point? J Allergy Clin Immunol 2000: 106: 1201.
55. Nieto A, Mazón A, Pamies R, et al. Efficacy of latex avoidance for primary prevention of latex sensitization in children with spina bifida. J Pediatr 2001: 140: 370-2.
56. Reider N, Kretz B, Menardi G, Ulmer H, Fritsch P. Outcome of a latex avoidance program in a high-risk population for latex allergy - a five year follow-up. Clin Exp Allergy 2002: 32: 708-13.
57. Vandenplas O, Larbanois A, Vanassche F, et al. Latex-induced occupational asthma: time trend in incidence and relationship with hospital glove policies. Allergy 2009: 64: 415-20.
58. Blumchen K, Bayer P, Buck D, et al. Effects of latex avoidance on latex sensitization, atopic status and allergic diseases in patients with spina bifida. Allergy, in press.
59. Szépfalusi Z, Seidl R, Bernert G, Dietrich W, Spitzauer S, Urbanek R. Latex sensitization in spina bifida appears disease-associated. J Pediatr 1999: 134: 344-8.
60. Hochleitner BW, Menardi G, Häussler B, Ulmer H, Kofler H, Reider N. Spina bifida as an independent risk factor for sensitization to latex. J Urol 2001: 166: 2370-4.
61. Eiwegger T, Dehlink E, Schwindt J, et al. Early exposure to latex products mediates latex sensitization in spina bifida but not in other diseases with comparable latex exposure rates. Clin Exp Allergy 2006: 36: 1242-6.